Sun, Taro settlements in US generic drug price-fixing litigation get preliminary approval
MLex Summary: Settlements reached by Sun Pharmaceuticals and Taro Pharmaceuticals with direct purchasers have been granted preliminary approval by a US judge. Under the agreements, Sun and Taro will pay $85...To view the full article, register now.
Already a subscriber? Click here to view full article